Text size
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Feb. 3 through Feb. 9, 2022. Source: InsiderScore.com, a Verity company.
Activist Holdings
Harley-Davidson (HOG)
H Partners increased its position in the maker of iconic motorcycles to 12.6 million shares. That figure accounts for 300,000 Harley-Davidson shares purchased from Jan. 14 through Jan. 24 at prices ranging from $33.23 to $37.91. H Partners now holds 8.2% of Harley-Davidson’s outstanding stock. H Partners further disclosed that it was given one seat on Harley-Davidson’s board through a cooperation agreement finalized on Feb. 2. Partner Jared Dourdeville will represent H Partners. As part of the agreement, H Partners will vote all of its stock in support of Harley-Davidson’s board at the coming 2022 shareholders meeting. H Partners will also abide by customary standstill agreements, including not raising its ownership stake to more than 14.99% of Harley-Davidson.
SOC Telemed (TLMD)
Warburg Pincus has disclosed a 33.5% stake in the telemedicine company, equal to 33,874,965 shares. SOC Telemed agreed on Feb. 2 to be acquired by healthcare investment firm Patient Square Capital for $3 per share. That same day, an affiliate of Warburg Pincus, SOC Holdings, entered into a support agreement with Patient Square and SOC Telemed, under which it will vote all of its shares in favor of the proposed acquisition. SOC Holdings, Warburg Pincus, and other affiliates share voting power over their SOC Telemed shares.
Original Filings
Verra Mobility (VRRM)
Scopia Capital Management disclosed a 5% stake in the mobility-technology company, equal to 7,826,574 shares. Scopia said that it had paid a total of $90,091,029, including commissions, for the Verra shares. The asset manager said that the shares “were undervalued and represented an attractive investment opportunity,” but that Scopia doesn’t have any specific plans for the company.
Increases In Holdings
Sierra Oncology (SRRA)
Longitude Capital Partners III reported an interest in the biopharmaceutical firm of 3,625,270 shares, including 1,477,125 underlying warrants. On Jan. 25, Longitude Capital exercised warrants at a cost of $13.20 per share to add 487,451 Sierra Oncology common shares. Longitude also bought 175,000 Sierra Oncology shares through a Jan. 31 offering that priced those shares at $27 each. Following those moves, Sierra now holds a 17.4% stake in Sierra Oncology.
Lee Enterprises (LEE)
Cannell Capital raised its position in the operator of local newspapers to 523,988 shares. From Jan. 27 through Feb. 9, Cannell Capital purchased a total of 96,353 Lee Enterprises shares at prices ranging from $32.86 to $38.41 apiece. Cannell has no plans or proposals in play regarding the fresh investment that now gives it an 8.8% interest in Lee Enterprises.
Email: [email protected]
